45.94
-0.1(-0.22%)
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
777
First IPO Date
December 28, 2021
| Name | Title | Pay | Year Born |
| Dongxiao Feng | Deputy General Manager | 0 | 1970 |
| Ruilin Sun | Deputy General Manager | 0 | 1980 |
| Mingjun Wang | GM, Acting Chief Financial Officer, Accounting Supervisor & Director | 0 | 1972 |
| Wen Liu | Secretary of the Board of Directors | 0 | 1990 |
Shanghai Model Organisms Center, Inc. engages in the research and development of genetically modified animal models in China. It develops tool, disease, fluorescent reporter, humanized, and immunodeficient mice; humanized, immunodeficient, disease, tool, and fluorescent reporter rats; and fluorescent-labeled, primary, and humanized cells. It also provides model customization, living body model, breeding, phenotypic analysis, and drug screening and evaluation services. The company was founded in 2000 and is headquartered in Shanghai, China.